CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Practice Management

Oncology NEWS International. Vol. 4 No. 1
Pages: 1  2  3  
Next
Comprehensive Health-Care Reform Appears Dead 

Look for Incremental Insurance Reform Steps With New Congress

January 1, 1995

WASHINGTON--Republican control of the US Congress means that the chance for comprehensive health-care reform, as envisioned by the Clinton administration, is over. But incremental changes to the health-care system, including insurance reforms that limit or exclude preexisting condition clauses, may gain significant support, says Stacey Beckhardt, of the American Society of Clinical Oncology (ASCO).

The midterm election victory gave the Republican party a 230 to 204 seat advantage in the House and a 53 to 47 margin in the Senate. As a result, the Republican Congress is likely to adhere to its "Contract with America," which was signed by more than 300 Republicans on the steps of the Capitol prior to the November elections.

That agenda includes measures to cut taxes, increase defense spending, and reduce government waste, said Ms. Beckhardt, ASCO's director of government relations. Oncology News International asked Ms. Beckhardt and other experts to predict what a Republican Congress may mean for health-care reform and oncology-related issues in coming months.

It is possible that Senate Republicans will pursue smaller health-care reform initiatives, such as malpractice reform and insurance reform, including portability of insurance, small group reform, and limits on preexisting conditions, Ms. Beckhardt said.

Moreover, Sen. Robert Dole (R-Kan)--and a number of other Republican senators--have presidential ambitions, so it is likely that the Republicans will try to "do something" on health care, Ms. Beckhardt said.

Martha McNeil, of the American Cancer Society (ACS), agreed that insurance reform has a good chance of passage in Congress. But it is not a priority with most Senate Republicans, so it will not happen right away, said Ms. McNeil, legislative representative for the ACS national public issues office. Eliminating preexisting condition clauses from insurance benefits is an important issue for many cancer patients, so it is "distressing" that insurance reform is not at the top of the congressional agenda, she said.

In the House, designated House Speaker, Rep. Newt Gingrich (R-Ga), has proposed significant changes to various committees that challenge the seniority system of that institution, Ms. Beckhardt said, and it is difficult to predict what these changes may mean for health-care reform.

Pages: 1  2  3  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Practice Management
Evidence on Practice Management
Guidelines on Practice Management
Patient Education on Practice Management
Clinical Trials on Practice Management
Practical Articles on Practice Management
Research and Reviews on Practice Management
All "Practice Management" results

CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy